Urinary Phosphorus Excretion and Cardiovascular Outcomes in Patients with Pre-Dialysis Chronic Kidney Disease: The KNOW-CKD Study

The relationship between 24-h urinary phosphorus excretion (24 h UPE) and cardiovascular disease in patients with pre-dialysis chronic kidney disease (CKD) has rarely been studied, despite the fact that the relationship between serum phosphorus level and the risk of a cardiovascular event is well es...

Full description

Bibliographic Details
Main Authors: Sang Heon Suh, Tae Ryom Oh, Hong Sang Choi, Chang Seong Kim, Eun Hui Bae, Seong Kwon Ma, Kook-Hwan Oh, Young Youl Hyun, Suah Sung, Soo Wan Kim
Format: Article
Language:English
Published: MDPI AG 2023-05-01
Series:Nutrients
Subjects:
Online Access:https://www.mdpi.com/2072-6643/15/10/2267
_version_ 1797598807494492160
author Sang Heon Suh
Tae Ryom Oh
Hong Sang Choi
Chang Seong Kim
Eun Hui Bae
Seong Kwon Ma
Kook-Hwan Oh
Young Youl Hyun
Suah Sung
Soo Wan Kim
author_facet Sang Heon Suh
Tae Ryom Oh
Hong Sang Choi
Chang Seong Kim
Eun Hui Bae
Seong Kwon Ma
Kook-Hwan Oh
Young Youl Hyun
Suah Sung
Soo Wan Kim
author_sort Sang Heon Suh
collection DOAJ
description The relationship between 24-h urinary phosphorus excretion (24 h UPE) and cardiovascular disease in patients with pre-dialysis chronic kidney disease (CKD) has rarely been studied, despite the fact that the relationship between serum phosphorus level and the risk of a cardiovascular event is well established. A total of 1701 patients with pre-dialysis CKD were finally included for the analyses and were divided into tertiles by 24 h UPE (first tertile (T1, 349.557 (mean) ± 88.413 (standard deviation)), second tertile (T2, 557.530 ± 50.738), and third tertile (T3, 851.695 ± 171.593). The study outcome was a six-point major adverse cardiac event (MACE). The median follow-up duration was 7.992 years. Kaplan–Meier curve analysis visualized that the cumulative incidences of a six-point MACE (<i>p</i> = 0.029) significantly differed from 24 h UPE levels, as the incidence rate of the study outcomes was highest in T1 and lowest in T3. Cox proportional hazard models unveiled that, compared to T1, the risk of a six-point MACE was significantly decreased in T3 (adjusted hazard ratio (HR) 0.376, 95% confidence interval (CI) 0.207 to 0.683). The restricted cubic spline curve analysis visualized an inverted S-shaped association between 24 h UPE level and the risk of a six-point MACE, indicating a significantly increased risk of a six-point MACE in patients with a low 24 h UPE level. In conclusion, low 24 h UPE is associated with adverse cardiovascular outcomes in patients with CKD. Our finding emphasizes that low 24 h UPE should not be a reliable marker for dietary restriction of phosphorus that essentially leads to better outcomes in patients with CKD.
first_indexed 2024-03-11T03:26:03Z
format Article
id doaj.art-09a864a2f46e47be86f7285cd0941c6e
institution Directory Open Access Journal
issn 2072-6643
language English
last_indexed 2024-03-11T03:26:03Z
publishDate 2023-05-01
publisher MDPI AG
record_format Article
series Nutrients
spelling doaj.art-09a864a2f46e47be86f7285cd0941c6e2023-11-18T02:43:59ZengMDPI AGNutrients2072-66432023-05-011510226710.3390/nu15102267Urinary Phosphorus Excretion and Cardiovascular Outcomes in Patients with Pre-Dialysis Chronic Kidney Disease: The KNOW-CKD StudySang Heon Suh0Tae Ryom Oh1Hong Sang Choi2Chang Seong Kim3Eun Hui Bae4Seong Kwon Ma5Kook-Hwan Oh6Young Youl Hyun7Suah Sung8Soo Wan Kim9Department of Internal Medicine, Chonnam National University Medical School, Gwangju 61469, Republic of KoreaDepartment of Internal Medicine, Chonnam National University Medical School, Gwangju 61469, Republic of KoreaDepartment of Internal Medicine, Chonnam National University Medical School, Gwangju 61469, Republic of KoreaDepartment of Internal Medicine, Chonnam National University Medical School, Gwangju 61469, Republic of KoreaDepartment of Internal Medicine, Chonnam National University Medical School, Gwangju 61469, Republic of KoreaDepartment of Internal Medicine, Chonnam National University Medical School, Gwangju 61469, Republic of KoreaDepartment of Internal Medicine, Seoul National University Hospital, Seoul 03080, Republic of KoreaDepartment of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul 03181, Republic of KoreaDepartment of Internal Medicine, Eulji Medical Center, Eulji University, Seoul 01830, Republic of KoreaDepartment of Internal Medicine, Chonnam National University Medical School, Gwangju 61469, Republic of KoreaThe relationship between 24-h urinary phosphorus excretion (24 h UPE) and cardiovascular disease in patients with pre-dialysis chronic kidney disease (CKD) has rarely been studied, despite the fact that the relationship between serum phosphorus level and the risk of a cardiovascular event is well established. A total of 1701 patients with pre-dialysis CKD were finally included for the analyses and were divided into tertiles by 24 h UPE (first tertile (T1, 349.557 (mean) ± 88.413 (standard deviation)), second tertile (T2, 557.530 ± 50.738), and third tertile (T3, 851.695 ± 171.593). The study outcome was a six-point major adverse cardiac event (MACE). The median follow-up duration was 7.992 years. Kaplan–Meier curve analysis visualized that the cumulative incidences of a six-point MACE (<i>p</i> = 0.029) significantly differed from 24 h UPE levels, as the incidence rate of the study outcomes was highest in T1 and lowest in T3. Cox proportional hazard models unveiled that, compared to T1, the risk of a six-point MACE was significantly decreased in T3 (adjusted hazard ratio (HR) 0.376, 95% confidence interval (CI) 0.207 to 0.683). The restricted cubic spline curve analysis visualized an inverted S-shaped association between 24 h UPE level and the risk of a six-point MACE, indicating a significantly increased risk of a six-point MACE in patients with a low 24 h UPE level. In conclusion, low 24 h UPE is associated with adverse cardiovascular outcomes in patients with CKD. Our finding emphasizes that low 24 h UPE should not be a reliable marker for dietary restriction of phosphorus that essentially leads to better outcomes in patients with CKD.https://www.mdpi.com/2072-6643/15/10/226724 h urinecardiovascular outcomechronic kidney diseasemajor adverse cardiac eventphosphorus
spellingShingle Sang Heon Suh
Tae Ryom Oh
Hong Sang Choi
Chang Seong Kim
Eun Hui Bae
Seong Kwon Ma
Kook-Hwan Oh
Young Youl Hyun
Suah Sung
Soo Wan Kim
Urinary Phosphorus Excretion and Cardiovascular Outcomes in Patients with Pre-Dialysis Chronic Kidney Disease: The KNOW-CKD Study
Nutrients
24 h urine
cardiovascular outcome
chronic kidney disease
major adverse cardiac event
phosphorus
title Urinary Phosphorus Excretion and Cardiovascular Outcomes in Patients with Pre-Dialysis Chronic Kidney Disease: The KNOW-CKD Study
title_full Urinary Phosphorus Excretion and Cardiovascular Outcomes in Patients with Pre-Dialysis Chronic Kidney Disease: The KNOW-CKD Study
title_fullStr Urinary Phosphorus Excretion and Cardiovascular Outcomes in Patients with Pre-Dialysis Chronic Kidney Disease: The KNOW-CKD Study
title_full_unstemmed Urinary Phosphorus Excretion and Cardiovascular Outcomes in Patients with Pre-Dialysis Chronic Kidney Disease: The KNOW-CKD Study
title_short Urinary Phosphorus Excretion and Cardiovascular Outcomes in Patients with Pre-Dialysis Chronic Kidney Disease: The KNOW-CKD Study
title_sort urinary phosphorus excretion and cardiovascular outcomes in patients with pre dialysis chronic kidney disease the know ckd study
topic 24 h urine
cardiovascular outcome
chronic kidney disease
major adverse cardiac event
phosphorus
url https://www.mdpi.com/2072-6643/15/10/2267
work_keys_str_mv AT sangheonsuh urinaryphosphorusexcretionandcardiovascularoutcomesinpatientswithpredialysischronickidneydiseasetheknowckdstudy
AT taeryomoh urinaryphosphorusexcretionandcardiovascularoutcomesinpatientswithpredialysischronickidneydiseasetheknowckdstudy
AT hongsangchoi urinaryphosphorusexcretionandcardiovascularoutcomesinpatientswithpredialysischronickidneydiseasetheknowckdstudy
AT changseongkim urinaryphosphorusexcretionandcardiovascularoutcomesinpatientswithpredialysischronickidneydiseasetheknowckdstudy
AT eunhuibae urinaryphosphorusexcretionandcardiovascularoutcomesinpatientswithpredialysischronickidneydiseasetheknowckdstudy
AT seongkwonma urinaryphosphorusexcretionandcardiovascularoutcomesinpatientswithpredialysischronickidneydiseasetheknowckdstudy
AT kookhwanoh urinaryphosphorusexcretionandcardiovascularoutcomesinpatientswithpredialysischronickidneydiseasetheknowckdstudy
AT youngyoulhyun urinaryphosphorusexcretionandcardiovascularoutcomesinpatientswithpredialysischronickidneydiseasetheknowckdstudy
AT suahsung urinaryphosphorusexcretionandcardiovascularoutcomesinpatientswithpredialysischronickidneydiseasetheknowckdstudy
AT soowankim urinaryphosphorusexcretionandcardiovascularoutcomesinpatientswithpredialysischronickidneydiseasetheknowckdstudy